Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65630 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Fluvoxketone (5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C13H15F3O2Couleur et forme :White PowderMasse moléculaire :260.10241Anastrozole Nitrile Acid (2-{3-[(1H-1,2,4-Triazol-1-yl)methyl]-5-(2-cyanopropan-2-yl)phenyl}-2-methylpropanoic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H20N4O2Couleur et forme :White PowderMasse moléculaire :312.15863Desthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :349.12739Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :Pale Yellow SolidMasse moléculaire :453.07613Hydroxybenzoyl Paliperidone (3-(2-(4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C23H28FN3O4Couleur et forme :Off-White SolidMasse moléculaire :429.20638Sodium Starch Glycolate Type B
CAS :Dextrins, nesoiFormule :C2H4O3·xNa·xUnspecifiedCouleur et forme :Off-White White PowderMasse moléculaire :515.6862Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N6O6Couleur et forme :White SolidMasse moléculaire :628.30093Darunavir Ethanolate
CAS :Sulfonamides used as drugsFormule :C27H37N3O7S·C2H6OCouleur et forme :White Beige PowderMasse moléculaire :593.74Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H3ClOSCouleur et forme :Brown LiquidMasse moléculaire :146.59 g/molPrasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H20FNO3S·HClCouleur et forme :White Off-White PowderMasse moléculaire :409.9Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C16H13N3O2SCouleur et forme :Dark Brown PowderMasse moléculaire :311.07285Gefitinib Related Compound B (N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H24ClFN4O3Couleur et forme :Light Yellow PowderMasse moléculaire :446.1521Oxcarbazepine Related Compound E (10(11H)-Oxo-5H-dibenz[b,f]azepine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H11NOCouleur et forme :PowderMasse moléculaire :209.084061,4-Sorbitan
CAS :Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormule :C6H12O5Couleur et forme :White Crystalline PowderMasse moléculaire :164.06847Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS :Nitrile function compounds, not elsewhere specified or includedFormule :C12H9F3N2O2Couleur et forme :White Off-White PowderMasse moléculaire :270.06161Teriflunomide Related Compound B (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide)
CAS :Nitrile function compounds, nesoiFormule :C10H7F3N2OCouleur et forme :White Yellow Crystalline PowderMasse moléculaire :228.05105Levetiracetam Crotonamide ((Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide)
CAS :Lactams, nesoiFormule :C8H12N2O2Couleur et forme :White Off-White SolidMasse moléculaire :168.2Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13NOCouleur et forme :White Powder ClumpyMasse moléculaire :199.25Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.42Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :White Beige PowderMasse moléculaire :315.16569Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :415.272264-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone))
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C9H10OCouleur et forme :Colorless LiquidMasse moléculaire :134.07316Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H27NO2Couleur et forme :Off-White PowderMasse moléculaire :277.4Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196Butylated Hydroxytoluene
CAS :Monophenols, nesoiFormule :C15H24OCouleur et forme :White PowderMasse moléculaire :220.18272Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS :Lactams, nesoiFormule :C26H25N5O5Couleur et forme :White Off-White PowderMasse moléculaire :487.18557Apixaban Related Compound E (Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C26H26N4O5Couleur et forme :Off-White Light Brown Cream PowderMasse moléculaire :474.19032Carbomer Homopolymer
CAS :Other acrylic polymers in primary forms (excluding elastomeric)Couleur et forme :White PowderClioquinol Related Compound A (5-Chloroquinolin-8-ol)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C9H6ClNOCouleur et forme :Off-White PowderMasse moléculaire :179.01379Naproxen Related Compound E ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C15H16O3Couleur et forme :White Crystalline PowderMasse moléculaire :244.29Regular Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderDofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C17H23N3OCouleur et forme :Off-White PowderMasse moléculaire :285.18411Atazanavir Related Compound A ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H15NO4Couleur et forme :Off-White White Powder ClumpyMasse moléculaire :189.10011Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :276.21O-Desmethyl Apremilast ((S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C21H22N2O7SCouleur et forme :Pale Yellow SolidMasse moléculaire :446.11477Rivaroxaban Open Oxomorpholine Ring ((S)-5-chloro-N-((3-(4-(2-hydroxy-N-(2-hydroxyethyl)acetamido) phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :White Off-White SolidMasse moléculaire :453.07613Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C36H36N6O10Couleur et forme :Off-White SolidMasse moléculaire :712.72Fluconazole Related Compound B (2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13FN6OCouleur et forme :White PowderMasse moléculaire :288.28Copovidone
CAS :Vinyl copolymers in primary forms, nesoiFormule :(C6H9NO)n(C4H6O2)mCouleur et forme :White Yellow PowderMasse moléculaire :197.23 g/molDesthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :421.12739Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H14FN·HClCouleur et forme :White PowderMasse moléculaire :191.11103N-Isopropyl Carvedilol (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C27H32N2O4Couleur et forme :Off-White SolidMasse moléculaire :448.23621Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C11H11F2N3O2Couleur et forme :White SolidMasse moléculaire :255.08193Dasatinib Related Compound B (N-(2-Chloro-6-methylphenyl)-2-{[2-methyl-6-(piperazin-1-yl)pyrimidin-4-yl]amino}thiazole-5-carboxamide)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C20H22ClN7OSCouleur et forme :White Off-White PowderMasse moléculaire :443.129514-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,4-dichlorophenyl)propan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H17Cl2NO·HClCouleur et forme :Off-White PowderMasse moléculaire :310.65Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29BrN4O5Couleur et forme :Cream PowderMasse moléculaire :568.13213Salmeterol Xinafoate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C25H37NO4·C11H8O3Couleur et forme :White PowderMasse moléculaire :415.27226Levetiracetam Related Compound B ((S)-2-aminobutanamide hydrochloride)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C4H10N2O·HClCouleur et forme :White Cream PowderMasse moléculaire :102.07931Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide)
Other aromatic organo-sulfur compounds (excluding pesticides)Couleur et forme :PowderMasse moléculaire :414.38Imidazole (1H-Imidazole)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C3H4N2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :68.08
